Stock listing
NASDAQ:IMMX Immix Biopharma, Inc. Stock
Home listing (NASDAQ) of Immix Biopharma, Inc.
Follow Immix Biopharma, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IMMX
$8.91 USD +0.69 (+8.4%)
Close on Oct 20, 2026
- Day range
- $8.26 – $9.03 USDOct 20, 2026
- Volume
- 1.22M sharesOct 20, 2026
- Market cap
- $738.7M USDAt the close on Oct 20, 2026 · price × 82.90M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IMMX · Home | $8.91 USD | +0.69 (+8.4%) | 1,215,718 | $8.26 | $9.03 | $8.26 | $8.22 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:IMMX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.91 | +0.69 | +8.4% | $8.26 | $9.03 | $8.26 | 1,215,718 | |
| $8.22 | +0.24 | +3.0% | $8.05 | $8.35 | $8.00 | 1,302,364 | |
| $7.98 | -0.70 | -8.1% | $8.67 | $8.67 | $7.95 | 1,503,565 | |
| $8.68 | +0.17 | +2.0% | $8.52 | $8.905 | $8.47 | 1,314,046 | |
| $8.51 | -0.18 | -2.1% | $8.60 | $8.87 | $8.42 | 1,360,377 | |
| $8.69 | -0.56 | -6.1% | $9.10 | $9.29 | $8.66 | 1,483,590 | |
| $9.25 | -0.21 | -2.2% | $9.42 | $9.56 | $9.18 | 936,248 | |
| $9.46 | +0.17 | +1.8% | $9.29 | $9.53 | $9.18 | 1,109,053 | |
| $9.29 | -0.20 | -2.1% | $9.34 | $9.37 | $8.96 | 1,288,951 | |
| $9.49 | -0.15 | -1.6% | $9.50 | $9.69 | $9.40 | 1,382,075 | |
| $9.64 | -0.49 | -4.8% | $10.20 | $10.20 | $9.515 | 1,214,600 | |
| $10.13 | +0.45 | +4.6% | $9.71 | $10.33 | $9.55 | 1,597,500 | |
| $9.68 | -0.55 | -5.4% | $10.35 | $10.37 | $9.48 | 2,548,000 | |
| $10.23 | -0.175 | -1.7% | $10.25 | $10.48 | $9.86 | 1,648,300 | |
| $10.41 | -0.135 | -1.3% | $10.61 | $11.25 | $10.39 | 2,408,600 | |
| $10.54 | -0.93 | -8.1% | $11.64 | $11.85 | $10.07 | 5,759,500 | |
| $11.47 | +0.50 | +4.6% | $10.82 | $11.84 | $10.70 | 995,600 | |
| $10.97 | -0.73 | -6.2% | $11.78 | $11.99 | $10.82 | 1,828,200 | |
| $11.70 | -0.22 | -1.8% | $11.87 | $11.97 | $11.19 | 1,535,800 | |
| $11.92 | -0.91 | -7.1% | $12.80 | $12.84 | $11.71 | 1,168,200 | |
| $12.83 | +0.36 | +2.9% | $12.45 | $12.90 | $12.31 | 948,100 | |
| $12.47 | -0.03 | -0.2% | $12.59 | $12.71 | $12.14 | 1,329,500 | |
| $12.50 | -0.22 | -1.7% | $12.68 | $12.84 | $12.34 | 4,183,900 | |
| $12.72 | +0.80 | +6.7% | $12.24 | $12.75 | $12.07 | 1,184,700 | |
| $11.92 | -0.22 | -1.8% | $12.28 | $12.46 | $11.75 | 1,421,900 | |
| $12.14 | -0.07 | -0.6% | $12.49 | $12.63 | $11.81 | 1,054,900 | |
| $12.21 | +0.07 | +0.6% | $12.44 | $12.59 | $11.98 | 1,079,600 | |
| $12.14 | -0.56 | -4.4% | $12.86 | $13.29 | $12.02 | 1,190,300 | |
| $12.70 | +0.39 | +3.2% | $12.08 | $12.77 | $11.91 | 1,656,300 | |
| $12.31 | -0.94 | -7.1% | $13.12 | $13.23 | $12.24 | 1,285,600 | |
| $13.25 | -0.66 | -4.7% | $13.70 | $13.89 | $12.75 | 1,420,200 | |
| $13.91 | +0.08 | +0.6% | $13.68 | $14.09 | $13.60 | 1,050,700 | |
| $13.83 | -0.13 | -0.9% | $14.14 | $14.14 | $13.52 | 987,200 | |
| $13.96 | -0.05 | -0.4% | $14.00 | $14.23 | $13.42 | 1,578,200 | |
| $14.01 | -0.02 | -0.1% | $13.86 | $14.26 | $13.62 | 1,277,400 | |
| $14.03 | +0.09 | +0.6% | $13.70 | $14.15 | $13.52 | 1,326,800 | |
| $13.94 | -0.37 | -2.6% | $14.06 | $14.17 | $13.76 | 1,143,400 | |
| $14.31 | +0.24 | +1.7% | $14.03 | $14.61 | $13.77 | 1,511,000 | |
| $14.07 | -0.40 | -2.8% | $14.45 | $14.55 | $13.80 | 1,385,000 | |
| $14.47 | +0.86 | +6.3% | $13.60 | $15.10 | $13.49 | 3,651,500 | |
| $13.61 | -0.05 | -0.4% | $13.66 | $13.80 | $12.90 | 1,415,400 | |
| $13.66 | +0.50 | +3.8% | $13.36 | $13.76 | $13.12 | 1,510,600 | |
| $13.16 | -0.03 | -0.2% | $12.98 | $13.20 | $12.69 | 1,666,200 | |
| $13.19 | +1.38 | +11.7% | $11.99 | $13.19 | $11.99 | 1,975,400 | |
| $11.81 | +0.47 | +4.1% | $11.12 | $11.86 | $11.06 | 1,352,600 | |
| $11.34 | +0.37 | +3.4% | $10.88 | $11.53 | $10.74 | 1,248,600 | |
| $10.97 | +0.05 | +0.5% | $10.85 | $11.08 | $10.36 | 1,295,400 | |
| $10.92 | -0.45 | -4.0% | $11.51 | $11.55 | $10.83 | 1,141,500 | |
| $11.37 | -0.12 | -1.0% | $11.49 | $11.72 | $10.93 | 1,549,100 | |
| $11.49 | +1.36 | +13.4% | $10.14 | $11.55 | $9.92 | 1,820,900 | |
| $10.13 | +0.41 | +4.2% | $9.755 | $10.33 | $9.66 | 1,600,300 | |
| $9.72 | -0.34 | -3.4% | $10.24 | $10.31 | $9.25 | 1,604,700 | |
| $10.06 | +0.52 | +5.5% | $9.52 | $10.10 | $9.52 | 1,220,400 | |
| $9.54 | +0.21 | +2.3% | $9.54 | $9.74 | $9.28 | 1,316,900 | |
| $9.33 | +0.91 | +10.8% | $8.53 | $9.38 | $8.53 | 1,868,900 | |
| $8.42 | +0.10 | +1.2% | $8.27 | $8.43 | $7.83 | 1,618,100 | |
| $8.32 | -0.23 | -2.7% | $8.61 | $8.72 | $8.21 | 1,590,600 | |
| $8.55 | +0.38 | +4.7% | $8.28 | $8.63 | $8.26 | 1,297,100 | |
| $8.17 | -0.27 | -3.2% | $8.47 | $8.66 | $8.12 | 1,367,500 | |
| $8.44 | -0.25 | -2.9% | $8.63 | $8.841 | $8.10 | 1,686,300 | |
| $8.69 | +0.17 | +2.0% | $8.63 | $9.39 | $8.58 | 1,988,100 | |
| $8.52 | -0.28 | -3.2% | $8.88 | $8.99 | $8.48 | 2,318,700 | |
| $8.80 | -0.61 | -6.5% | $9.23 | $9.455 | $8.775 | 995,800 | |
| $9.41 | -0.16 | -1.7% | $9.78 | $9.785 | $9.265 | 1,806,600 | |
| $9.57 | +0.77 | +8.7% | $8.915 | $9.685 | $8.83 | 2,481,350 | |
| $8.80 | -1.45 | -14.1% | $10.00 | $10.05 | $8.67 | 3,919,461 |
- Ticker
- NASDAQ:IMMX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 5, 2026
Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 34 slides
Latest news
Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference
Oct 5, 2026
Closed $10.13 (+4.6%) on Oct 5, 2026
Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
Sep 30, 2026
Closed $10.23 (-1.7%) on Oct 1, 2026
Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
Sep 29, 2026
Closed $10.54 (-8.1%) on Sep 29, 2026
Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for Relapsed/Refracto...
Sep 29, 2026
Closed $10.54 (-8.1%) on Sep 29, 2026
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Aug 4, 2026
Closed $9.33 (+10.8%) on Aug 4, 2026
Financings
Public offering of common stock
Sep 29, 2026
Announced: US$125M · US$11 a share · J.P. Morgan
Dealers: J.P. Morgan (lead)
Buyers: Eventide Asset Management; Janus Henderson Investors; Ridgeback Capital Investments L.P.; Wellington Management
Use of proceeds: Fund NXC-201 development, working capital and general corporate purposes
Decks
Investor Presentation (September 2026)
Investor deck · 34 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 31 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 50 slides · May 2026
Technical Presentation (February 2026)
Technical · 17 slides · Feb 6, 2026
Immix Biopharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 104 in all · newest Oct 5, 2026 · oldest 2021
- Decks
- 10 decks · latest September 2026
Where Immix Biopharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IMMX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:IMMX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Immix Biopharma, Inc.